Revuforj (revumenib) is a novel menin inhibitor indicated for the treatment of relapsed or refractory acute leukemia harboring KMT2A gene translocations.

How to Purchase Revuforj (Revumenib)

Overseas Purchase

Patients may choose to consult and purchase Revuforj at hospital pharmacies or licensed retail pharmacies in countries or regions where the drug has been launched.

Since drug prices may be affected by factors such as regional differences and exchange rate fluctuations, patients need to make a budget and plan in advance before purchasing.

Purchase via Medical Service Institutions

Patients can consult domestic overseas medical service institutions that cooperate with international pharmacies or pharmaceutical companies.

These institutions usually provide legal import channels and offer professional consultation and guidance.

Precautions for Purchasing Revuforj (Revumenib)

Strictly Follow Doctor's Instructions

The dosage needs to be adjusted based on the patient's body weight and whether a strong CYP3A4 inhibitor is used in combination (e.g., the standard adult dosage is 270mg twice daily; when used with an inhibitor, the dosage should be reduced to 160mg).

Regular monitoring of electrocardiogram (ECG), serum potassium, serum magnesium, and liver function is required to prevent adverse reactions such as QT interval prolongation.

Contraindications and High-Risk Populations

Absolute Contraindications: Pregnant women (may cause fetal malformations), uncontrolled QT interval prolongation (baseline QTcF > 450msec).

Caution Required: Patients with hepatic impairment, a history of thrombosis, or heart disease need doctors to evaluate the risk-benefit ratio before use.

Be Alert to Drug Interactions

Concurrent use with strong CYP3A4 inducers (e.g., rifampicin) should be avoided, as this may reduce the efficacy of Revuforj.

Dosage adjustment is necessary when Revuforj is used in combination with strong CYP3A4 inhibitors (e.g., posaconazole).

Monitoring of Adverse Reactions

Common side effects include bleeding, nausea, muscle pain, and infection.

If symptoms such as fever, dyspnea, or palpitations occur (which may indicate differentiation syndrome or QT prolongation), immediate medical attention is required.

How to Identify Authentic vs. Counterfeit Revuforj (Revumenib)

Packaging and Appearance

The 25mg tablets are pink, oval-shaped, and engraved with "S" and "25".

The 110mg tablets are beige, oval-shaped, and engraved with "S" and "110".

The 160mg tablets are purple, oval-shaped, and engraved with "S" and "160".

Packaging Integrity: Authentic products are packaged in original aluminum bottles containing desiccants. The label should display the batch number, expiration date, and manufacturer information (Syndax Pharmaceuticals).

Instruction Manual and Label

Authentic products are accompanied by an English instruction manual, which details ingredients, indications, contraindications, and adverse reactions. Counterfeit products may have typographical errors or missing content.

Check for the FDA approval number and NDC (National Drug Code) number.